About
RefleXion Medical is a biotargeting oncology company based in Hayward, California, founded in 2009 by Sam Mazin, Ph.D., and Akshay Nanduri. The company is dedicated to developing innovative cancer treatment technologies that combine medical physics, nuclear medicine, and radiotherapy. Their flagship product, the RefleXion X1 machine, is FDA-cleared for various forms of radiotherapy, including stereotactic body radiotherapy (SBRT) and intensity-modulated radiation therapy (IMRT). The core innovation of RefleXion is its biology-guided radiotherapy (BgRT) platform, which utilizes the cancer's own biology to guide real-time radiation delivery. This technology integrates positron emission tomography (PET) imaging with stereotactic radiotherapy, allowing for precise targeting of tumors, even those that move during treatment. This approach aims to enhance treatment accuracy and improve patient outcomes for both localized and metastatic cancer cases.
Technologies
Keywords
Company Information
- Employees310
- Founded2009
- Annual Revenue$108600000
- Total Funding$663712002
Location
25841 Industrial Boulevard, Hayward, California, United States, 94545